NEW YORK (GenomeWeb News) – The US Food and Drug Administration plans to formally launch its newly formed Serious Adverse Events Consortium in “the next couple of weeks,” an FDA official told GenomeWeb News today.
 
As GenomeWeb News reported this morning, the FDA is forming a consortium of drugmakers and academic research groups that aims to study how genetic biomarkers contribute to serious adverse events.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.